Medical genomics contribution in clinical decisions in oncology
Abstract
biology have contributed to establishing the molecular bases
for understanding and diagnosing many pathological processes.
Genomic medicine and the concept of personalized medicine
arise. The genetic information of each individual makes it possible
to identify variants in the genome that confer risk for diseases such
as cancer or respond differentially to therapies. We carried out a
systematic and qualitative bibliographic review, with the aim of
knowing and evaluating the contribution of genomics in decisionmaking in clinical oncology, focusing on hereditary predisposition
syndromes to breast/ovarian and colorectal cancer, due to its
greater frequency, to know in what situation we find ourselves in
at a national level. The development and application of genomics
in oncology clinical practice in our country has been increasing,
with applications in the prevention, diagnosis and treatment of
hereditary predisposition syndromes to cancer. However, the lack
of dissemination of its importance and how to contact the centers
that provide these services, among health personnel and users, is
highlighted.
Downloads
Copyright (c) 2022 Agustina Arias, Daniela Arin, Martina Barbierato, Agustina Maffioli, Marcia Pérez, Mathias Queirolo, Virginia Rodríguez Sande, Alfonso Cayota
This work is licensed under a Creative Commons Attribution 4.0 International License.
The authors retain their copyright and assign to the journal the right of first publication of their work, which will be simultaneously subject to the Creative Commons Attribution 4.0 International License. that allows sharing the work as long as the initial publication in this magazine is indicated.
